Opus Genetics, Inc.
IRD· Nasdaq
IRDOpus Genetics, Inc.
Filed Aug 3, 2018 · 10-Q · 34 days after period end · 0001140361-18-035394
| Metric | Q2 2018 | Q2 2017 | Q2 2016 | Q2 2015 |
|---|---|---|---|---|
| Net Income | -$3.84M | $947.06K | -$1.77M | -$3.23M |
| EPS Diluted | -$0.12 | $0.03 | -$0.08 | -$0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Opus Genetics, Inc. · CIK 1228627 · Engraved from SEC EDGAR
ended Jun 30, 2018 · filed Aug 3, 2018 · 34 d after period end
